Silverarc Capital Management, LLC Prometheus Biosciences, Inc. Put Options Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$36.06 - $117.21 $1.16 Million - $3.79 Million
-32,300 Reduced 15.78%
172,400 $19 Million
Q3 2022

Oct 28, 2022
SELL
$28.17 - $59.01 $2.73 Million - $5.72 Million
-97,000 Reduced 32.15%
204,700 $12.1 Million
Q2 2022

Jul 25, 2022
BUY
$22.39 - $38.94 $6.76 Million - $11.7 Million
301,700 New
301,700 $8.52 Million

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email